carfilzomib,dexamethasone,isatuximab
sanofi,amgen
oral abstracts day2 #ims2022 nct03275285: phase 3 - isatuximab, carf &amp; dex vs carf and dex in relapse multiple myeloma (ikema) #mmsm #multiplemyeloma #curemyeloma 
Multiple Myeloma Education Platform for Myeloma Community